Clinical trial
A Controlled Trial to Assess the Immunogenicity and Efficacy of Three Vaccine Dosing Strategies in HIV Infected Adults
NCT00764998 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Controlled Trial to Assess the Immunogenicity and Efficacy of Three Vaccine Dosing Strategies in HIV Infected Adults
- Lead sponsor
- Ottawa Hospital Research Institute
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2008
- Completion date
- August 31, 2009
- Enrollment
- 285 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
hiv, influenza